- Home
- SGD vs HSCS Comparison
SGD vs HSCS Comparison
Compare SGD & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGD | HSCS |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.5M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SGD | HSCS |
|---|---|---|
| Price | $0.42 | $2.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | ★ 724.1K | 40.1K |
| Earning Date | 11-14-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,970,752.00 | $6,250.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2770.15 | N/A |
| 52 Week Low | $0.64 | $2.01 |
| 52 Week High | $3.03 | $6.47 |
Technical Indicators
Market Signals| Indicator | SGD | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 24.91 | 51.68 |
| Support Level | $0.74 | $2.52 |
| Resistance Level | $1.22 | $2.91 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 2.16 | 80.56 |
Price Performance
Historical ComparisonAbout SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.